Formulation comprising histone deacetylase inhibitors

Details for Australian Patent Application No. 2005237251 (hide)

Owner Desitin Arzneimittel GmbH TopoTarget Germany AG

Inventors Franke, Hanshermann; Lennartz, Peter; Maurer, Alexander B.; Hovelmann, Sascha; Martin, Elke; Hentsch, Bernd

Agent Pizzeys

Pub. Number AU-B-2005237251

PCT Pub. Number WO2005/105055

Priority 04010333.5 30.04.04 EP

Filing date 2 May 2005

Wipo publication date 10 November 2005

Acceptance publication date 4 November 2010

International Classifications

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/19 (2006.01)

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105055 Priority application(s): WO2005/105055

4 November 2010 Application Accepted

  Published as AU-B-2005237251

3 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237254-Combinations comprising a S1P receptor agonist and a JAK3 kinase inhibitor

2005237248-Pack with a partial quantity of fine cut and method for manufacturing packs with a partial quantity of fine cut